In hospitalized COVID-19 patients, elevations in aminotransferases, particularly alanine aminotransferase (ALT) and aspartate aminotransferase (AST), are reported in up to 50% of cases, typically in the absence of overt hepatic failure, which often leads to their underestimation in clinical significance [1]. The gene discussed is GPT; the disease is Hepatic failure.